BIOMAT Database Logo BIOMAT Database Logo

Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer. 2014

Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao

Previous studies have assessed the prognostic role of serum carbohydrate antigen 19-9 (CA 19-9) concentration in patients with gastric cancer, but the findings from those studies were inconsistent. We searched the PubMed and Web of Science databases to find eligible studies assessing the prognostic role of CA 19-9 in patients with gastric cancer. Twelve studies with a total of 5,072 gastric cancer patients were finally included into the meta-analysis. The pooled hazard ratio (HR) with corresponding 95 % confidence interval (95 % CI) for overall survival were calculated to assess the prognostic role of CA 19-9 in patients with gastric cancer. Overall, elevated serum concentration of CA 19-9 (>37 U/mL) was associated with poorer overall survival in patients with gastric cancer (fixed-effects HR = 1.36, 95 % CI 1.24-1.48, P < 0.001). Subgroup analysis by study design further showed that elevated serum concentration of CA 19-9 was associated with poorer overall survival in patients with gastric cancer. There was no obvious risk of publication bias. Elevated concentration of serum CA 19-9 is associated with poorer overall survival in patients with gastric cancer.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D056726 Genetic Association Studies The analysis of a sequence such as a region of a chromosome, a haplotype, a gene, or an allele for its involvement in controlling the phenotype of a specific trait, metabolic pathway, or disease. Candidate Gene Identification,Candidate Gene Analysis,Candidate Gene Association Studies,Candidate Gene Association Study,Gene Discovery,Genotype-Phenotype Association,Genotype-Phenotype Associations,Genotype-Phenotype Correlation,Genotype-Phenotype Correlations,Analyses, Candidate Gene,Analysis, Candidate Gene,Association Studies, Genetic,Association Study, Genetic,Association, Genotype-Phenotype,Associations, Genotype-Phenotype,Candidate Gene Analyses,Correlation, Genotype-Phenotype,Correlations, Genotype-Phenotype,Discovery, Gene,Gene Analyses, Candidate,Gene Analysis, Candidate,Gene Identification, Candidate,Genetic Association Study,Genotype Phenotype Association,Genotype Phenotype Associations,Genotype Phenotype Correlation,Genotype Phenotype Correlations,Identification, Candidate Gene,Studies, Genetic Association,Study, Genetic Association
D018395 CA-19-9 Antigen Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors. 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine,Antigen CA-19-9,Gastrointestinal Cancer Antigen,Sialyl Le(a),Sialyl Lewis A,Sialyl Lewis A Antigen,Sialyl Lewis(a) Tetrasaccharide,CA 19-9 Antigen,CA 19.9 Antigen,NAG-1,3-F-1,4-GN,Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc,alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc,A, Sialyl Lewis,Antigen CA 19 9,Antigen, CA 19-9,Antigen, CA 19.9,Antigen, CA-19-9,CA 19 9 Antigen,CA-19-9, Antigen,Cancer Antigen, Gastrointestinal,Lewis A, Sialyl
D020022 Genetic Predisposition to Disease A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. Genetic Predisposition,Genetic Susceptibility,Predisposition, Genetic,Susceptibility, Genetic,Genetic Predispositions,Genetic Susceptibilities,Predispositions, Genetic,Susceptibilities, Genetic

Related Publications

Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
Carbohydrate antigen 19-9 in tissues and sera from patients with gastric cancer.
January 1990, Oncology,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
Mucosal expression of carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with gastritis and gastric cancer.
January 1999, Cancer detection and prevention,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
[Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
January 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
February 2017, Surgery today,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
[Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
December 1984, Igaku kenkyu. Acta medica,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
January 2015, Disease markers,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer.
August 2020, Biomedicines,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
[Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
March 1991, Changgeng yi xue za zhi,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer.
December 2016, Clinical colorectal cancer,
Jiuchang Xiao, and Xiaoyan He, and Zengyan Wang, and Jiying Hu, and Fang Sun, and Feng Qi, and Shugang Yang, and Zhenyu Xiao
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
January 2001, Journal of clinical gastroenterology,
Copied contents to your clipboard!